Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT03869814
Non-invasive Liquid Biopsy Analysis of Epigenomics Signatures in Multiple Cancer Types
Sponsor: ClearNote Health
View on ClinicalTrials.gov
Summary
ClearNote Health is developing a test from whole blood for the early detection of multiple cancers. The goal of this study is to employ genomics, epigenomics and proteomics methodology for the detection of cancer signal in the blood of subjects with solid tumors.
Key Details
Gender
All
Age Range
21 Years - 80 Years
Study Type
OBSERVATIONAL
Enrollment
20000
Start Date
2018-04-05
Completion Date
2029-09-13
Last Updated
2026-05-15
Healthy Volunteers
Yes
Conditions
Interventions
OTHER
Blood Draw
Blood Draw
Locations (1)
ClearNote Health, Inc.
San Diego, California, United States